Motley Fool Money Best & Worst of 2022
Dec 16, 2022
Ron Gross, an investment analyst at The Motley Fool, joins senior analysts Emily Flippen and Jason Moser for an engaging look back at 2022. They reflect on the year’s biggest business stories, tallying both remarkable successes and questionable investments. Highlights include surprising performances from brands like Salesforce and Campbell Soup, as well as the nominations for CEO of the Year. Listeners can also anticipate insights on rising stocks like Booz Allen Hamilton and NextEra Energy, blending market analysis with a touch of humor.
AI Snips
Chapters
Books
Transcript
Episode notes
Outset Medical and FDA Hold
- Outset Medical's stock experienced a temporary dip due to an FDA-requested hold on device shipments.
- However, the stock rebounded after shipments resumed, highlighting the importance of due diligence.
Campbell Soup's Turnaround
- Campbell Soup's performance in 2022 was a surprise, with its stock trading at a five-year high.
- The company's successful turnaround, led by CEO Mark Klaus, involved modernizing labels and introducing new products.
Axon Enterprise's Success
- Axon Enterprise had a surprisingly successful year, exceeding expectations despite initial predictions.
- Strong revenue growth, government contracts, international expansion, and resilient software sales contributed to their success.
